Ibandronate Sodium (AuroMedics Pharma LLC)
Welcome to the PulseAid listing for the Ibandronate Sodium drug offered from AuroMedics Pharma LLC. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AuroMedics Pharma LLC |
NON-PROPRIETARY NAME: | Ibandronate Sodium |
SUBSTANCE NAME: | IBANDRONATE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-08-19 |
END MARKETING DATE: | 0000-00-00 |
Ibandronate Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Ibandronate Sodium from AuroMedics Pharma LLC |
LABELER NAME: | AuroMedics Pharma LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3(mg/3mL) |
START MARKETING DATE: | 2015-08-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55150-191_27dfd868-9642-432d-a31b-02121e4039ee |
PRODUCT NDC: | 55150-191 |
APPLICATION NUMBER: | ANDA205332 |
Other IBANDRONATE SODIUM Pharmaceutical Manufacturers / Labelers: